ProfileGDS5822 / ILMN_2669823
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 55% 1% 30% 14% 13% 11% 41% 25% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 124.355
GSM1276600PDAC Late Ablation Control 26.71
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 113.630
GSM1276603PDAC Late Ablation 21014
GSM1276604PDAC Late Ablation 39.613
GSM1303940PDAC Late Ablation_anti-CTLA4 19.911
GSM1303941PDAC Late Ablation_anti-CTLA4 219.541
GSM1303942PDAC Late Ablation_anti-CTLA4 312.525